Ethics
Ethics and Malpractice Statement
Ethical considerations
Kiru journal is committed to scientific integrity at all stages of the research and editorial process. In this regard, it adheres to internationally recognized ethical standards for scholarly publishing and best editorial practices, in accordance with the guidelines established by the Committee on Publication Ethics (COPE) (http://publicationethics.org/) and the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/).
The journal requires all authors to comply with ethical principles governing research involving human subjects, in line with major international guidelines, including the World Medical Association (WMA) Declaration of Helsinki, the Belmont Report (Ethical Principles and Guidelines for the Protection of Human Subjects of Research), and the International Ethical Guidelines for Health-related Research Involving Humans issued by the Council for International Organizations of Medical Sciences (CIOMS).
Compliance with current Peruvian regulations is also required, particularly the Clinical Trials Regulation (Supreme Decree No. 021-2017-SA) and the Ethical Considerations for Health Research (Ministerial Resolution No. 233-2020-MINSA), which mandate informed consent, approval by an Institutional Research Ethics Committee (IREC), and, where applicable, registration with the National Institute of Health (INS).
Clinical trials conducted in Peru must be registered in the Peruvian Clinical Trials Registry (REPEC) (https://ensayosclinicos-repec.ins.gob.pe/). Studies conducted in other countries must be registered in the World Health Organization’s International Clinical Trials Registry Platform (ICTRP) (https://trialsearch.who.int/). If a clinical trial was not registered or was registered retrospectively, authors must provide a clear justification.
Manuscripts must demonstrate compliance with these principles in order to minimize potential risks to participants. This compliance will be assessed by the editorial board and peer reviewers. All research studies must have been approved by a research ethics committee and must explicitly state that informed consent was obtained from participants.
Research involving animals must have been approved by an Animal Research Ethics Committee (or equivalent body), specifying the responsible institution and country.
Kiru journal also endorses the San Francisco Declaration on Research Assessment (DORA) (https://sfdora.org/read/).
Informed Consent
Authors must obtain written informed consent from all study participants and retain this documentation, which may be requested by the journal at any time.
In case reports, images, photographs, and clinical data must be fully anonymized to prevent identification of participants. No personal data that could compromise confidentiality should be included.
Adoption on the DORA Declaration
Date: Novenber 2, 2025
Kiru journal supports the principles of open access and open science and adopts the San Francisco Declaration on Research Assessment (DORA), in alignment with its editorial policies and international ethical standards.
DORA (https://sfdora.org) promotes improvements in the evaluation of scholarly research by emphasizing quality, rigor, fairness, and transparency over traditional metrics. In this context, Kiru journal is committed to assessing research based on its scientific quality and relevance, ensuring a fair and transparent evaluation process.
Accordingly, the journal establishes that:
- Submitted manuscripts must be original and unpublished.
- Responsible authorship is promoted.
- The CRediT taxonomy is adopted to specify individual author contributions.
- Data availability and sharing are encouraged.
- Data citation must follow the Vancouver style.
- All articles are assigned a Digital Object Identifier (DOI).
- ORCID identifiers are required for all authors.
- Diversity and recognition of scientific contributions are promoted.
- The journal progressively implements open science policies.
